Years of development. A patent filed. A working prototype sitting on your bench. Investors are asking the question you’ve been putting off:
“Are you going to manufacture this yourself, or license it?”
I’ve watched people agonize over this decision for months. And honestly, most of them end up choosing based on gut feeling rather than analysis. That works sometimes. It also leads to million-dollar mistakes.
Three Roads, Very Different Destinations
Self-manufacturing. You build it. You own the whole chain from lab to loading dock. You capture the full margin. Contract manufacturing. You design it. A third party makes it. You own the customer relationship but outsource the factory floor. Licensing. You license the IP. Someone else handles manufacturing, marketing, and sales. You collect royalties.Each path has a completely different risk profile, capital requirement, and ceiling. Getting this right means matching the path to your actual situation—not the situation you wish you were in.
Self-Manufacturing
This makes sense when you’ve got strong demand validation—50+ buyer conversations, pilot commitments or signed LOIs, confidence that the market will absorb 10,000+ units a year.
Your margins need to justify the upfront spend. We’re talking gross margins in the 60-75% range, projected net margins of 30-40% after COGS, with a realistic path to $5M+ in annual revenue within two years.
Sometimes IP protection forces the decision—if your technology involves trade secrets that patents alone can’t protect, you may need to keep manufacturing in-house.
The capital reality: $1.2M-4.5M in the first year. Tooling and equipment alone run $500K-2M. Working capital eats $300K-1M. Operations add another $400K-1.5M annually.
You’re committing real money before shipping a single unit. Ramp-up takes 12-18 months. But if everything clicks, those margins are hard to beat.
Contract Manufacturing
This is the middle path, and for many companies it’s the smartest first step.
You’ve validated demand but not at scale—maybe 5-10 pilot programs closed, but you’re not sure about 10,000-unit annual volume yet. Capital is limited—you’d rather test the market with $200K-500K than bet $2M on manufacturing equipment. Or speed matters—contract manufacturers have existing capacity, so you can go from prototype to production in 3-6 months instead of 12-18.
First-year investment: $150K-800K. That’s 80-90% less than self-manufacturing.
The tradeoff is margin. Gross margin drops from 65-75% to 35-50%. You give up some control over production schedules and quality. But if demand underperforms, you’ve risked $200K instead of $2M. That’s a much better place to be wrong from.
Licensing
Licensing works when you don’t have manufacturing capital (maybe you’re a research lab, university spinout, or solo inventor), the market is large but fragmented across multiple industries, or your strength is R&D and you don’t actually want to run a product company.
Most people approach licensing backwards. They find one interested company, negotiate in isolation, and accept whatever terms are offered. The result: licensing fees 60-80% below market value.
The better approach is to create a competitive environment. Identify 8-10 potential licensees across global markets. Engage them simultaneously using progressive disclosure—not showing all your cards at once. Narrow to the top 3-5 candidates for deeper analysis. Run parallel test programs so multiple parties are invested. Meanwhile, get end customers excited about the technology so demand-side pull pressures manufacturers to move faster.
Then negotiate from strength with multiple interested parties.
A client of ours with patented magnetic bearing technology followed this playbook. Engaged 10 global manufacturers, narrowed to 3, structured territorial licenses across 3 continents. Total licensing fees came in 350% higher than a single-company deal would have yielded.
How to Think Through the Decision
Start with demand. If you’ve got 50+ customer commitments, self-manufacturing is on the table. If you’ve got 8-15 pilot commitments, contract manufacturing fits. If you’re still at concept stage, licensing is probably the path.
Then look at capital. $2M+ available? Self-manufacturing is viable. $200K-800K? Contract manufacturing. Under $200K? Licensing may be the only realistic option.
Then ask what you actually want to build. If you want a product company, manufacturing (self or contract) is the road. If you want to stay in the lab, license it.
A lot of successful companies blend these paths. They start with contract manufacturing to test the market with limited risk, then transition to self-manufacturing in year 3-4 as demand proves out and revenue from early years funds the equipment investment.
There’s no universally correct answer. But there is a universally correct first step: talk to real buyers before you commit. Know the pricing thresholds. Understand integration requirements. Map procurement cycles.
The worst commercialization decision isn’t picking the wrong path. It’s picking any path before confirming that customers will actually buy what you’re building.